News

FDA Approves New Antifungal Drug Cresemba
Meghan Ross, Associate Editor
The FDA today approved isavuconazonium sulfate for adults with invasive aspergillosis and invasive mucormycosis.
Meghan Ross, Associate Editor
There’s no guessing which team retired pharmacist Irving Rider is rooting for this March Madness.
Ryan Marotta, Assistant Editor
The FDA today authorized the use of the first device approved to treat dialysis-related amyloidosis.
Ryan Marotta, Assistant Editor
Sagent Pharmaceuticals is voluntarily recalling 6 lots of its atracurium besylate injection following FDA observations of practices at the manufacturer’s site that could potentially affect the products’ sterility.
Davy James, Associate Editor
After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States.
Meghan Ross, Associate Editor
Tweeting about quitting may help smokers actually kick the habit.
Michael R. Page, PharmD, RPh
In light of misrepresented statistics and overstated fears about statin-related adverse events, here are 3 of the biggest myths your patients may have heard about these life-saving medications—and the facts
Meghan Ross, Associate Editor
A man from Virginia has pleaded guilty to first-degree murder of a pharmacist.

Association News

Known as one of the best political journalists covering Washington, DC, Amy Walter, national editor of The Cook Political Report, will keynote the National Association of Chain Drug Stores RxIMPACT Day.
Roughly three-quarters of pharmacists said they would feel confident or very confident substituting an interchangeable biosimilar for its branded biologic counterpart if the two products share the same nonproprietary name.
The Academy of Managed Care Pharmacy applauds the House Ways & Means Committee for approving legislation that contains measures to prevent prescription drug abuse under the Medicare Part D program.
GPhA applauds the bipartisan reintroduction of the Food and Drug Administration Safety Over Sequestration Act.
Urging recognition of pharmacists as health care providers under Medicare Part B, NACDS cited that retail pharmacies are often the most readily accessible health care provider.

Pharmacy Market News

The planned studies include a multicenter, open-label Phase 1b/2 study of lenvatinib plus pembrolizumab in select solid tumors and an open-label, single-arm, multicenter Phase 1b/2 study to evaluate the efficacy and safety of eribulin in combination with pembrolizumab in metastatic triple-negative breast cancer.
First Databank will be the primary distributor of Polyglot’s proprietary Meducation simplified patient medication instructions to the hospital, ambulatory and pharmacy markets in the US and Canada.

Strategic Alliance Partner News

$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$